• United States
• /
• Biotech
• /
• NasdaqGM:CRSP

What CRISPR Therapeutics Stock's Expanded Casgevy Approval Means For Shareholders

Weekly Picks

When GPS fails: this small cap is fixing a $54B drone problem

61 followersusers have followed this narrative

0 commentsusers have commented on this narrative

I Went Looking for a Crashed Space Stock.I Found a Machine That Remembers Earth.

58 followersusers have followed this narrative

1 commentusers have commented on this narrative

deyan_89mg6 on Space Exploration Technologies ·

Attractive / Buy on weakness / positive, but valuation-disciplined

38 followersusers have followed this narrative

Broadcom's $115 Billion AI Opportunity Changes The Valuation Equation

34 followersusers have followed this narrative

2 commentsusers have commented on this narrative

CoreWeave’s business is booming. Its bonds say it’s in trouble. Which do you believe?

How drones are changing the world of business, not just the battlefield

Drones are more than just toys. They are now changing the face of numerous industries. We take a look into the wide world of drones.

About NasdaqGM:CRSP

CRISPR Therapeutics

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

High growth potential with adequate balance sheet.

Similar Companies

Market Insights

Recently Updated Narratives

Kee Ming’s Next Growth Leg Is Already Taking Shape

1 followerusers have followed this narrative

ServisFirst Bancshares : What They Said vs. What They Did

Butler National (Buks) outperforms.

12 followersusers have followed this narrative

Popular Narratives

AI Factory Demand And Physical AI Workloads Will Drive Multi‑Year Upside Potential

1630 followersusers have followed this narrative

8 commentsusers have commented on this narrative

AI Infrastructure And Cloud Commitments Will Drive Long-Term Upside For This Business

1720 followersusers have followed this narrative

AI Infrastructure And Cloud Services Will Drive Long-Term Value In This Retail Giant

1767 followersusers have followed this narrative

Trending Discussion

GEMOILSpelliscy on Terra Balcanica Resources ·

Dear Sir,I recently read your article on Orestocks, which led me to discover this website. Thank you for that. It certainly appears to have very good potential, but I should like to make a public request to the owner of this service.Is there no way for me to leave a comment on a stock if it lacks a “narrative”? I have looked, but I cannot seem to find a way to do so.This is rather inconvenient if one’s focus, much like my own, is on “high risk / 100x reward” types of stocks such as this one.I do apologize for leaving this note as a comment on your article. I share your view on this stock, as you can likely tell from the category of mining stocks in which I personally place Terra Balcanica, as I mentioned just a few sentences prior.I should also like to give you a friendly reminder to make the minor mathematical correction on this website as well, just as you have corrected it on Orestocks. The corrected $0.0107 is every bit as extraordinary as $0.0089; there is no difference in that regard. I had done the calculations myself before reading your work and arrived at the same conclusion. However, I must confess that I have become a little disappointed that the market does not seem to have noticed it.Warm regards,

|

Agree with the split between a great business and a great investment. One variable I'd add to the bear case is that a big slice of that $89bn data centre line still comes from a handful of hyperscalers who are all ramping their own custom silicon, so mix shift rather than demand collapse could be what pressures the 75% gross margin first. If Q3 lands near the $108bn guide with margins holding, your $240 base case looks fair; a capex pause from even one large customer would pull it toward the bear end quickly.

|